glp1 tirzepatide Beyond glycemia: Comparing to GLP-1 analogues | Reviews in Endocrine and Metabolic Disorders Frontiers | GLP-1/GIP dual agonist

More than one-third of people who helped develop the 2023 guidelines for treating children with obesity had undisclosed financial ties to obesity drugmakers, a paper finds.

Using an integrated ligand and structure-based virtual screening pipeline, explicitly combining complementary ligand-based descriptors, multi-fingerprint similarity, electrostatic similarity, pharmacophore modeling, and multi-conformation docking under a consensus-driven selection strategy, we were able to identify three chemically distinct classes of GLP-1R agonist candidates: GQB47810, a non-peptidic molecule

President-elect Donald J

This article was originally posted on the American Salon | People who experience rapid weight loss with Ozempic and similar medications are driving demand for the Sofwave cosmetic treatment.

underwriters and carriers are navigating the landscape differently

The frustration of eating well, exercising consistently, and still not seeing the results you deserve can be demoralizing.